AIDS Therapies
Early Antiviral Therapy Impacts Viremia
Published in AIDS Weekly, April 17th, 2000
These scientists, part of a research team at the University Hospital of Geneva conducted a study comparing the initiation of antiviral therapy at primary HIV-1 infection (PHI) diagnosis, during chronic infection with CD4 counts greater than or equal to 500 (immunocompetent), and after development of immunosuppression ("Time of initiation of antiretroviral therapy: Impact on HIV-1 viremia," AIDS, 2000;14(3):243-249).
S. Yerly and colleagues examined antiviral effectiveness at each of the three levels of HIV infection. The groups...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of AIDS Weekly
Source: AIDS Weekly (2000-04-17)
More Articles from AIDS Weekly
- Thrombosis
Clogged Vessels Seen in AIDS Patients with Risk Factors - AIDS Therapies
HAART Improves Survival for HIV+ in Europe - Adverse Drug Effects
Combination Treatment May Precipitate Sensory Neuropathy - At-Risk Populations
Dramatic Reduction in New HIV Infections Reported Among Injecting Drug Users in New York City - Biochemistry
RNA Mediates Protein-Protein Binding in Opportunistic Infection - Cognitive Deficit
People with AIDS Illnesses More Prone to Memory Problems - More from this issue of AIDS Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
